GRP
KNSA icon

Global Retirement Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Global Retirement Partners’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59K Buy
+103
New +$5.34K ﹤0.01% 3596
2025
Q4 		$4.25K Buy
+103
New +$4.13K ﹤0.01% 3487

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Global Retirement Partners's KNSA Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 103 shares worth $6.59K. The stake represents ﹤0.01% of the portfolio and ranks #3596 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in KNSA as recently as Q4 2025.

Global Retirement Partners first reported a position in KNSA in Q4 2025 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Global Retirement Partners held 103 shares of Kiniksa Pharmaceuticals worth $6.59K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3596 holding.
  • Global Retirement Partners first reported a position in Kiniksa Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.